Drug Discovery

Can Experimental Drug Be the Breakthrough for Bladder Cancer?
Research & Development Can Experimental Drug Be the Breakthrough for Bladder Cancer?

Paul Simmonite, a 53-year-old deli owner from Keighley, has been battling aggressive bladder cancer. His journey through various treatments underscores both his resilience and the potential for groundbreaking advancements in cancer therapy. Diagnosed in August 2021 after noticing blood in his

Can Ultrasound-Activated Nanoparticles Revolutionize Drug Delivery?
Tech & Innovation Can Ultrasound-Activated Nanoparticles Revolutionize Drug Delivery?

The pursuit of more effective and precise medical treatments has led to the exploration of innovative drug delivery systems, one of which involves the use of ultrasound-activated nanoparticles. These systems represent a promising solution for overcoming the challenges associated with conventional

Can Programmable Nanomachines Revolutionize Drug Delivery Systems?
Tech & Innovation Can Programmable Nanomachines Revolutionize Drug Delivery Systems?

The field of nanotechnology is rapidly evolving, with significant advancements being made in the development of nanomachines—tiny biological devices capable of performing complex functions within living organisms. These innovations hold the potential to revolutionize various fields, particularly d

Dextromethorphan Shows Promise for Treating Lung Fibrosis in Study
Research & Development Dextromethorphan Shows Promise for Treating Lung Fibrosis in Study

Lung fibrosis, or pulmonary fibrosis, is a debilitating disease characterized by the excessive buildup of fibrillar collagen, leading to scarring in the lung tissue. This scarring makes lung tissues stiff and reduces their elasticity, resulting in severe breathing difficulties and decreased oxygen

AI and ICR Collaborate to Repurpose Drugs for Childhood Brain Cancer
Research & Development AI and ICR Collaborate to Repurpose Drugs for Childhood Brain Cancer

The Institute of Cancer Research (ICR) in London is teaming up with Healx, a biotech firm known for its expertise in artificial intelligence (AI) and machine learning, to develop potential new therapies for diffuse intrinsic pontine glioma (DIPG), a rare and currently untreatable form of childhood

Digital Health in 2024: Surprising Shifts, AI Growth, and New Challenges
Tech & Innovation Digital Health in 2024: Surprising Shifts, AI Growth, and New Challenges

The digital health landscape in 2024 has been marked by unexpected developments, rapid advancements, and new challenges. Industry executives have reflected on the year's most surprising and impactful occurrences, providing insights into the evolving dynamics of healthcare technology. This

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later